Active 0 6 0 6 B-chronic_disease
psychiatric 7 18 7 18 I-chronic_disease
disorder 19 27 19 27 I-chronic_disease
that 28 32 28 32 O
would 33 38 33 38 O
prevent 39 46 39 46 O
eligibility 47 58 47 58 O
for 59 62 59 62 O
WLS 63 66 63 66 B-treatment
or 67 69 67 69 O
impede 70 76 70 76 O
adherence 77 86 77 86 O
to 87 89 87 89 O
CLI 90 93 90 93 B-chronic_disease
, 93 94 93 94 O
including 95 104 95 104 O
clinically 105 115 105 115 B-chronic_disease
significant 116 127 116 127 I-chronic_disease
depression 128 138 128 138 I-chronic_disease
( 139 140 139 140 O
hospitalization 140 155 140 155 O
or 156 158 156 158 O
suicidal 159 167 159 167 O
ideation 168 176 168 176 O
) 176 177 176 177 O
in 178 180 178 180 O
past 181 185 181 185 B-upper_bound
12 186 188 186 188 I-upper_bound
months 189 195 189 195 I-upper_bound

An 0 2 196 198 O
upper 3 8 199 204 O
limit 9 14 205 210 O
of 15 17 211 213 O
BMI 18 21 214 217 B-bmi
was 22 25 218 221 O
set 26 29 222 225 O
to 30 32 226 228 O
avoid 33 38 229 234 O
rare 39 43 235 239 O
outliers 44 52 240 248 O
in 53 55 249 251 O
BMI 56 59 252 255 O

Any 0 3 256 259 O
female 4 10 260 266 B-gender
who 11 14 267 270 O
is 15 17 271 273 O
currently 18 27 274 283 O
nursing 28 35 284 291 O
, 35 36 291 292 O
planning 37 45 293 301 O
a 46 47 302 303 O
pregnancy 48 57 304 313 B-pregnancy
, 57 58 313 314 O
known 59 64 315 320 O
or 65 67 321 323 O
suspected 68 77 324 333 O
to 78 80 334 336 O
be 81 83 337 339 O
pregnant 84 92 340 348 B-pregnancy
, 92 93 348 349 O
or 94 96 350 352 O
has 97 100 353 356 O
a 101 102 357 358 O
positive 103 111 359 367 B-pregnancy
pregnancy 112 121 368 377 I-pregnancy
screen 122 128 378 384 O

Any 0 3 385 388 O
medical 4 11 389 396 O
condition 12 21 397 406 O
preventing 22 32 407 417 O
eligibility 33 44 418 429 O
for 45 48 430 433 O
WLS 49 52 434 437 B-clinical_variable
including 53 62 438 447 O
but 63 66 448 451 O
not 67 70 452 455 O
limited 71 78 456 463 O
to 79 81 464 466 O
micronutrient 82 95 467 480 O
deficiencies 96 108 481 493 O
( 109 110 494 495 O
e.g. 110 114 495 499 O
iron 115 119 500 504 O
) 119 120 504 505 O
refractory 121 131 506 516 O
to 132 134 517 519 O
medical 135 142 520 527 B-treatment
therapy 143 150 528 535 I-treatment
or 151 153 536 538 O
inflammatory 154 166 539 551 B-chronic_disease
bowel 167 172 552 557 I-chronic_disease
disease 173 180 558 565 I-chronic_disease

BMI 0 3 566 569 B-bmi
≥ 4 5 570 571 O
35 6 8 572 574 B-lower_bound
to 9 11 575 577 O
69 12 14 578 580 B-upper_bound
kg 15 17 581 583 I-upper_bound
/ 17 18 583 584 I-upper_bound
m2 18 20 584 586 I-upper_bound

Biopsy 0 6 587 593 B-treatment
must 7 11 594 598 O
confirm 12 19 599 606 O
definite 20 28 607 615 O
or 29 31 616 618 O
borderline 32 42 619 629 O
NASH 43 47 630 634 O
with 48 52 635 639 O
a 53 54 640 641 O
minimum 55 62 642 649 O
histological 63 75 650 662 O
NASH 76 80 663 667 B-clinical_variable
Activity 81 89 668 676 I-clinical_variable
Score 90 95 677 682 I-clinical_variable
of 96 98 683 685 O
≥ 99 100 686 687 O
3 101 102 688 689 B-lower_bound

Current 0 7 690 697 O
enrollment 8 18 698 708 O
in 19 21 709 711 O
another 22 29 712 719 B-treatment
clinical 30 38 720 728 I-treatment
trial 39 44 729 734 I-treatment
or 45 47 735 737 O
receipt 48 55 738 745 O
of 56 58 746 748 O
an 59 61 749 751 O
investigational 62 77 752 767 B-treatment
study 78 83 768 773 I-treatment
drug 84 88 774 778 I-treatment
within 89 95 779 785 O
6 96 97 786 787 B-upper_bound
months 98 104 788 794 I-upper_bound
prior 105 110 795 800 I-upper_bound
to 111 113 801 803 O
the 114 117 804 807 O
baseline 118 126 808 816 O
liver 127 132 817 822 B-treatment
biopsy 133 139 823 829 I-treatment

Evidence 0 8 830 838 O
of 9 11 839 841 O
other 12 17 842 847 O
chronic 18 25 848 855 B-chronic_disease
liver 26 31 856 861 I-chronic_disease
disease 32 39 862 869 I-chronic_disease

Initiation 0 10 870 880 O
of 11 13 881 883 O
high 14 18 884 888 O
dose 19 23 889 893 O
vitamin 24 31 894 901 B-treatment
E 32 33 902 903 I-treatment
( 34 35 904 905 O
> 35 36 905 906 O
400 36 39 906 909 B-lower_bound
IU 40 42 910 912 I-lower_bound
per 43 46 913 916 O
day 47 50 917 920 O
) 50 51 920 921 O
or 52 54 922 924 O
other 55 60 925 930 O
medications 61 72 931 942 B-treatment
which 73 78 943 948 O
could 79 84 949 954 O
alter 85 90 955 960 O
NASH 91 95 961 965 O
histology 96 105 966 975 O
at 106 108 976 978 O
any 109 112 979 982 O
time 113 117 983 987 O
after 118 123 988 993 O
baseline 124 132 994 1002 B-treatment
liver 133 138 1003 1008 I-treatment
biopsy 139 145 1009 1015 I-treatment
or 146 148 1016 1018 O
during 149 155 1019 1025 O
the 156 159 1026 1029 O
trial 160 165 1030 1035 O

Liver 0 5 1036 1041 B-treatment
biopsy 6 12 1042 1048 I-treatment
for 13 16 1049 1052 O
clinical 17 25 1053 1061 O
indication 26 36 1062 1072 O
to 37 39 1073 1075 O
evaluate 40 48 1076 1084 O
for 49 52 1085 1088 O
NASH 53 57 1089 1093 O
within 58 64 1094 1100 O
1 65 66 1101 1102 B-upper_bound
year 67 71 1103 1107 I-upper_bound
of 72 74 1108 1110 O
enrollment 75 85 1111 1121 O

No 0 2 1122 1124 O
evidence 3 11 1125 1133 O
of 12 14 1134 1136 O
any 15 18 1137 1140 O
other 19 24 1141 1146 O
liver 25 30 1147 1152 B-chronic_disease
disease 31 38 1153 1160 I-chronic_disease
by 39 41 1161 1163 O
history 42 49 1164 1171 O
, 49 50 1171 1172 O
screening 51 60 1173 1182 O
tests 61 66 1183 1188 O
or 67 69 1189 1191 O
histological 70 82 1192 1204 O
evaluation 83 93 1205 1215 O

Non 0 3 1216 1219 O
- 3 4 1219 1220 O
compensated 4 15 1220 1231 O
liver 16 21 1232 1237 B-chronic_disease
disease 22 29 1238 1245 I-chronic_disease
with 30 34 1246 1250 O
any 35 38 1251 1254 O
of 39 41 1255 1257 O
the 42 45 1258 1261 O
following 46 55 1262 1271 O

Poorly 0 6 1272 1278 O
controlled 7 17 1279 1289 O
Type 18 22 1290 1294 B-chronic_disease
2 23 24 1295 1296 I-chronic_disease
diabetes 25 33 1297 1305 I-chronic_disease
mellitus 34 42 1306 1314 I-chronic_disease
( 43 44 1315 1316 I-chronic_disease
T2DM 44 48 1316 1320 I-chronic_disease
) 48 49 1320 1321 I-chronic_disease
defined 50 57 1322 1329 O
as 58 60 1330 1332 O
hemoglobin 61 71 1333 1343 B-clinical_variable
A1C 72 75 1344 1347 I-clinical_variable
( 76 77 1348 1349 I-clinical_variable
HgbA1c 77 83 1349 1355 I-clinical_variable
) 83 84 1355 1356 I-clinical_variable
> 85 86 1357 1358 O
10 87 89 1359 1361 B-lower_bound
% 89 90 1361 1362 I-lower_bound

Prior 0 5 1363 1368 O
history 6 13 1369 1376 O
of 14 16 1377 1379 O
WLS 17 20 1380 1383 B-chronic_disease

Stable 0 6 1384 1390 O
dose 7 11 1391 1395 O
of 12 14 1396 1398 O
vitamin 15 22 1399 1406 B-treatment
E 23 24 1407 1408 I-treatment
that 25 29 1409 1413 O
was 30 33 1414 1417 O
started 34 41 1418 1425 O
12 42 44 1426 1428 B-lower_bound
months 45 51 1429 1435 I-lower_bound
or 52 54 1436 1438 O
more 55 59 1439 1443 O
prior 60 65 1444 1449 O
to 66 68 1450 1452 O
biopsy 69 75 1453 1459 O
is 76 78 1460 1462 O
allowed 79 86 1463 1470 O

Weight 0 6 1471 1477 B-clinical_variable
reduction 7 16 1478 1487 I-clinical_variable
of 17 19 1488 1490 O
> 20 21 1491 1492 O
5 21 22 1492 1493 B-lower_bound
% 22 23 1493 1494 I-lower_bound
between 24 31 1495 1502 O
baseline 32 40 1503 1511 O
liver 41 46 1512 1517 B-treatment
biopsy 47 53 1518 1524 I-treatment
and 54 57 1525 1528 O
enrollment 58 68 1529 1539 O
, 68 69 1539 1540 O
as 70 72 1541 1543 O
weight 73 79 1544 1550 B-clinical_variable
loss 80 84 1551 1555 I-clinical_variable
> 85 86 1556 1557 O
5 86 87 1557 1558 O
% 87 88 1558 1559 O
may 89 92 1560 1563 O
change 93 99 1564 1570 O
NASH 100 104 1571 1575 O
severity 105 113 1576 1584 O

Wilson 0 6 1585 1591 B-chronic_disease
disease 7 14 1592 1599 I-chronic_disease

ages 0 4 1600 1604 B-age
12 5 7 1605 1607 B-lower_bound
- 7 8 1607 1608 O
19 8 10 1608 1610 B-upper_bound
years 11 16 1611 1616 I-upper_bound

alcohol 0 7 1617 1624 B-clinical_variable
intake 8 14 1625 1631 I-clinical_variable
> 15 16 1632 1633 I-clinical_variable
10 16 18 1633 1635 I-clinical_variable
gm 19 21 1636 1638 I-clinical_variable
/ 21 22 1638 1639 I-clinical_variable
day 22 25 1639 1642 I-clinical_variable
females 26 33 1643 1650 I-clinical_variable
& 34 35 1651 1652 I-clinical_variable
> 36 37 1653 1654 I-clinical_variable
20 37 39 1654 1656 I-clinical_variable
gm 40 42 1657 1659 I-clinical_variable
/ 42 43 1659 1660 I-clinical_variable
day 43 46 1660 1663 I-clinical_variable
males 47 52 1664 1669 I-clinical_variable

alpha-1 0 7 1670 1677 B-chronic_disease
- 7 8 1677 1678 I-chronic_disease
antitrypsin 8 19 1678 1689 I-chronic_disease
( 20 21 1690 1691 I-chronic_disease
A1AT 21 25 1691 1695 I-chronic_disease
) 25 26 1695 1696 I-chronic_disease
deficiency 27 37 1697 1707 I-chronic_disease

autoimmune 0 10 1708 1718 B-chronic_disease
hepatitis 11 20 1719 1728 I-chronic_disease

hemochromatosis 0 15 1729 1744 B-chronic_disease

hemoglobin 0 10 1745 1755 B-clinical_variable
< 11 12 1756 1757 O
10 12 14 1757 1759 B-upper_bound
g 15 16 1760 1761 I-upper_bound
/ 16 17 1761 1762 I-upper_bound
dL 17 19 1762 1764 I-upper_bound
; 19 20 1764 1765 O
white 21 26 1766 1771 B-clinical_variable
blood 27 32 1772 1777 I-clinical_variable
cell 33 37 1778 1782 I-clinical_variable
count 38 43 1783 1788 I-clinical_variable
< 44 45 1789 1790 O
3,500 45 50 1790 1795 B-upper_bound
cells 51 56 1796 1801 I-upper_bound
/ 56 57 1801 1802 I-upper_bound
mm3 57 60 1802 1805 I-upper_bound
, 60 61 1805 1806 O
platelet 62 70 1807 1815 B-clinical_variable
count 71 76 1816 1821 I-clinical_variable
< 77 78 1822 1823 O
130,000 78 85 1823 1830 B-upper_bound
cells 86 91 1831 1836 I-upper_bound
/ 91 92 1836 1837 I-upper_bound
mm3 92 95 1837 1840 I-upper_bound
of 96 98 1841 1843 I-upper_bound
blood 99 104 1844 1849 I-upper_bound
, 104 105 1849 1850 O
direct 106 112 1851 1857 B-clinical_variable
bilirubin 113 122 1858 1867 I-clinical_variable
> 123 124 1868 1869 O
1.0 124 127 1869 1872 B-lower_bound
mg 128 130 1873 1875 I-lower_bound
/ 130 131 1875 1876 I-lower_bound
dL 131 133 1876 1878 I-lower_bound
, 133 134 1878 1879 O
total 135 140 1880 1885 B-clinical_variable
bilirubin 141 150 1886 1895 I-clinical_variable
> 151 152 1896 1897 O
3 152 153 1897 1898 B-lower_bound
mg 154 156 1899 1901 I-lower_bound
/ 156 157 1901 1902 I-lower_bound
dL 157 159 1902 1904 I-lower_bound
, 159 160 1904 1905 O
albumin 161 168 1906 1913 B-clinical_variable
< 169 170 1914 1915 O
3.2 170 173 1915 1918 B-upper_bound
g 174 175 1919 1920 I-upper_bound
/ 175 176 1920 1921 I-upper_bound
dL 176 178 1921 1923 I-upper_bound
, 178 179 1923 1924 O
international 180 193 1925 1938 B-clinical_variable
normalized 194 204 1939 1949 I-clinical_variable
ratio 205 210 1950 1955 I-clinical_variable
( 211 212 1956 1957 I-clinical_variable
INR 212 215 1957 1960 I-clinical_variable
) 215 216 1960 1961 I-clinical_variable
> 217 218 1962 1963 O
1.4 218 221 1963 1966 B-lower_bound

hepatitis 0 9 1967 1976 B-chronic_disease
B 10 11 1977 1978 I-chronic_disease

hepatitis 0 9 1979 1988 B-chronic_disease
C 10 11 1989 1990 I-chronic_disease

minimum 0 7 1991 1998 O
BMI 8 11 1999 2002 B-bmi
per 12 15 2003 2006 O
current 16 23 2007 2014 O
guidelines 24 34 2015 2025 O
for 35 38 2026 2029 O
WLS 39 42 2030 2033 B-chronic_disease
in 43 45 2034 2036 O
adolescents 46 57 2037 2048 O

use 0 3 2049 2052 O
of 4 6 2053 2055 O
medications 7 18 2056 2067 B-treatment
known 19 24 2068 2073 O
to 25 27 2074 2076 O
cause 28 33 2077 2082 O
fatty 34 39 2083 2088 B-chronic_disease
liver 40 45 2089 2094 I-chronic_disease
for 46 49 2095 2098 O
> 50 51 2099 2100 O
2 52 53 2101 2102 B-lower_bound
consecutive 54 65 2103 2114 I-lower_bound
weeks 66 71 2115 2120 I-lower_bound
in 72 74 2121 2123 O
past 75 79 2124 2128 O
year 80 84 2129 2133 O
( 85 86 2134 2135 O
i.e. 86 90 2135 2139 O
systemic 91 99 2140 2148 B-treatment
glucocorticoids 100 115 2149 2164 I-treatment
, 115 116 2164 2165 O
tetracycline 117 129 2166 2178 B-treatment
, 129 130 2178 2179 O
anabolic 131 139 2180 2188 B-treatment
steroids 140 148 2189 2197 I-treatment
, 148 149 2197 2198 O
valproic 150 158 2199 2207 B-treatment
acid 159 163 2208 2212 I-treatment
) 163 164 2212 2213 O

